Peloso GM, Natarajan P. Insights from population-based analyses of plasma lipids across the allele frequency spectrum. Curr Opin Genet Dev. 2018;50:1-6. doi:10.1016/j.gde.2018.01.003
Broeckx BJG, Derrien T, Mottier S, et al. An exome sequencing based approach for genome-wide association studies in the dog. Sci Rep. 2017;7(1):15680. doi:10.1038/s41598-017-15947-9
Hui KY, Fernandez-Hernandez H, Hu J, et al. Functional variants in the gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease. Sci Transl Med. 2018;10(423). doi:10.1126/scitranslmed.aai7795
Bobbili DR, Lal D, May P, et al. Exome-wide analysis of mutational burden in patients with typical and atypical Rolandic epilepsy. Eur J Hum Genet. 2018;26(2):258-264. doi:10.1038/s41431-017-0034-x
Zhao Z, Bi W, Zhou W, VandeHaar P, Fritsche LG, Lee S. UK Biobank Whole-Exome Sequence Binary Phenome Analysis with Robust Region-Based Rare-Variant Test. Am J Hum Genet. 2020;106(1):3-12. doi:10.1016/j.ajhg.2019.11.012
Ellrott K, Bailey MH, Saksena G, et al. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. Cell Syst. 2018;6(3):271-281.e7. doi:10.1016/j.cels.2018.03.002
Bihlmeyer NA, Brody JA, Smith AV, et al. ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals. Circ Genom Precis Med. 2018;11(1):e001758. doi:10.1161/CIRCGEN.117.001758
Kong SW, Lee IH, Liu X, Hirschhorn JN, Mandl KD. Measuring coverage and accuracy of whole-exome sequencing in clinical context. Genet Med. 2018;20(12):1617-1626. doi:10.1038/gim.2018.51
Miao D, Margolis CA, Vokes NI, et al. Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors. Nat Genet. 2018;50(9):1271-1281. doi:10.1038/s41588-018-0200-2
Artomov M, Stratigos AJ, Kim I, et al. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing. J Natl Cancer Inst. 2017;109(12). doi:10.1093/jnci/djx083